Table 2. Sensitivities in non-small cell lung cancer.
Characteristic | miRNAs positive | Total patients | Sensitivity (%) |
---|---|---|---|
Atypical adenomatoid hyperplasia | 7 | 46 | 15.2 |
Adenocarcinoma in situ | 37 | 107 | 34.5 |
Invasive adenocarcinoma | 38 | 85 | 44.7 |
Others | 2 | 9 | 22.2 |
Total patients | 84 | 247 | 34.0 |